CRISPR-enabled biosensing of cancer-associated DNA methylation in cell-free DNA: molecular architectures, molecular sampling constraints, and translational biosensor engineering
No native-state Cas methylation assay identified in this review has established clinically usable diagnostic performance, and reported analytical limits of detection and methylation-fraction discrimination cannot be extrapolated to clinical sensitivity without accounting for input, recovery, fragmentation, background,...